Investor profile
Karen Silaika
Private equity, Venture debt & Associate Director (Georgia) at Janus Henderson Investors
Karen Silaika is an Associate Director (Georgia) at Janus Henderson Investors, whose known portfolio counts 10 companies.
Is Karen Silaika a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- FinTechHealthcare
Contacts
Affiliated funds' portfolios
Associate Director (Georgia) at Janus Henderson Investors, whose known portfolio counts 10 companies
- Relmada Therapeutics
- Achieve Life Science
- Ray Therapeutics
- Ovid Therapeutics
- Solid Biosciences
- Maze Therapeutics
- Ambrosia Biosciences
- Calyxo
- Adagene
- Longeveron
Investor Profile
Founders in the listed sectors FinTech and Healthcare, and focus areas Biotech, Diagnostics, Drug Discovery and MedTech fall inside that listing.
Janus Henderson Investors appears in Growth, Late-Stage and Series B rounds across its known deals.
The firm portfolio and the focus above give founders context on whether Karen Silaika matches their raise.
Colleagues at Janus Henderson Investors
Henrik Krasilnikoff Jeppesen
Senior Member
Denver, United States
Noe Marquez
Investment Service Analyst
Denver, United States
Belinda Martha Mongoyo
Angel Investors
United States
Yaser Moustafa
Head of EM Private Investments
United Arab Emirates
Rupert Pennant Rea
Chairman
London, United Kingdom
Erdem Kilic
Senior Director
Frankfurt, Germany
Christopher Haddad
Principal
United Arab Emirates
Cara Owen
Senior Legal Counsel
Denver, United States
Frequently asked questions
Who is Karen Silaika?
Karen Silaika is a private equity investor and venture debt investor based in Denver, Colorado, United States, listed as Associate Director (Georgia) at Janus Henderson Investors. The known portfolio of that firm counts 10 companies. That portfolio belongs to the firm, not to Karen Silaika personally.
What does Karen Silaika invest in?
Listed sectors include FinTech and Healthcare; listed focus areas include Biotech, Diagnostics, Drug Discovery and MedTech. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Karen Silaika invest at?
Janus Henderson Investors appears in Growth, Late-Stage and Series B rounds across its known deals, and Karen Silaika is listed there as Associate Director (Georgia). Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Karen Silaika listed at?
Karen Silaika is listed as Associate Director (Georgia) at Janus Henderson Investors. 8 other people in the database share a firm with Karen Silaika.
How do I contact Karen Silaika?
An email address, a phone number and a LinkedIn page are on file for Karen Silaika. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal